Allen, David J and Harris, John P ORCID: 0000-0001-9606-9480
(2017)
Methods for ascertaining norovirus disease burdens.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 13 (11).
pp. 2630-2636.
This is the latest version of this item.
Text
HVI commentry_DJA-JPH.docx - Author Accepted Manuscript Available under License : See the attached licence file. Download (145kB) |
|
Text
HVI commentry_DJA-JPH.docx - Author Accepted Manuscript Available under License : See the attached licence file. Download (145kB) |
|
Text
HVI-Commentary-author-copy.pdf - Author Accepted Manuscript Available under License : See the attached licence file. Download (221kB) |
Abstract
Norovirus is the commonest cause of gastrointestinal disease worldwide in. Infections with norovirus occur in all age groups, however, the highest incidence is in children aged less than five years. Surveillance of norovirus is complicated because most people do not contact medical services when they are ill. Nevertheless, Public health laboratory surveillance worldwide has demonstrated the dominance of GII.4 viruses in the population. Better epidemiological surveillance and outbreak investigations, coupled with wider implementation of molecular-based laboratory diagnostics are leading to better estimates of the burden of norovirus infections as well as improved outbreak control. Recent advances in cell culture systems for norovirus and current research investigating the distribution of norovirus-associated disease in the population, for whom the disease burden is greatest, understanding host susceptibility factors, and methodologies for ascertaining cases, are important in increasing our understanding of norovirus. The key to surveillance of norovirus is allying the epidemiology with surveillance of virology. With recent advances in laboratory culture systems for norovirus, next generation sequencing technologies, improved diagnostics and measuring phenotypic characteristics of noroviruses, there are new opportunities to advance understanding of this common and important human pathogen that will help design strategies for vaccine and antiviral development, and how these might be best deployed to control norovirus infection.
Item Type: | Article |
---|---|
Additional Information: | 2044-6055 Harris, John P Lopman, Ben A Cooper, Ben S O'Brien, Sarah J Journal Article England BMJ Open. 2013 Jul 13;3(7). pii: e003060. doi: 10.1136/bmjopen-2013-003060. Print 2013.## TULIP Type: Articles/Papers (Journal) ## |
Uncontrolled Keywords: | norovirus, calicivirus, infectious disease, transmssion, disease burden |
Depositing User: | Symplectic Admin |
Date Deposited: | 14 Feb 2020 17:07 |
Last Modified: | 19 Jan 2023 00:11 |
DOI: | 10.1080/21645515.2017.1360455 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3069387 |
Available Versions of this Item
-
Methods for ascertaining norovirus disease burdens. (deposited 01 Aug 2017 06:31)
-
Methods for ascertaining norovirus disease burdens. (deposited 07 Dec 2018 12:46)
- Methods for ascertaining norovirus disease burdens. (deposited 14 Feb 2020 17:07) [Currently Displayed]
-
Methods for ascertaining norovirus disease burdens. (deposited 07 Dec 2018 12:46)